| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
IgA nephropathy | 0.524 | 0.808 |
|
disease | 0.100 | None | 0.973 | 112 | 0 | 1980 | 2020 | |||||||||
|
immunoglobulin heavy constant alpha 1 | 0.617 | 0.692 |
|
disease | 0.100 | None | 0.982 | 109 | 0 | 1994 | 2020 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2019 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2019 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2019 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2014 | 2018 | |||||||||
|
microRNA 148b | 0.592 | 0.692 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2012 | 2018 | |||||||||
|
microRNA 192 | 0.503 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2019 | |||||||||
|
microRNA 205 | 0.482 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2010 | 2018 | |||||||||
|
HORMAD2 and MTMR3 antisense RNA 1 | 0.839 | 0.308 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2011 | 2015 | |||||||||
|
esterase activator | 0.716 | 0.308 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2019 | |||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2017 | |||||||||
|
microRNA let-7b | 0.493 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2015 | 2016 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2014 | 2016 | |||||||||
|
microRNA 29c | 0.496 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2018 | |||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1997 | 1999 | |||||||||
|
alpha-thalassemia/mental retardation syndrome, type 1 | 0.711 | 0.577 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2015 | |||||||||
|
microRNA 374b | 0.621 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
microRNA 365b | 0.769 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
IgA nephropathy, susceptibility to, 2 | 1.000 | 0.115 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
T cell receptor alpha constant | 0.691 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
major histocompatibility complex, class II, DP beta 2 (pseudogene) | 0.743 | 0.500 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
hypoparathyroidism | 0.593 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 |